Eboni Murraine
Family · Huntsville, ALNPI 1275170565
Payments from drug & device makers
Across 490 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AstraZeneca$890
- Bayer$798
- GSK$754
- AbbVie$479
- Sanofi-aventis U.S. LLC$338
- plus $2K from 24 others
What the payments were for
- Food & beverage$8,467100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 218 | $2,973 |
| AstraZeneca | 44 | $890 |
| Bayer | 37 | $798 |
| GSK | 39 | $754 |
| AbbVie | 28 | $479 |
| Sanofi-aventis U.S. LLC | 17 | $338 |
| Boehringer Ingelheim | 17 | $299 |
| Lilly USA, LLC | 14 | $294 |
| Exact Sciences | 7 | $165 |
| Amgen | 8 | $148 |
| Neurocrine Biosciences, Inc. | 1 | $136 |
| Astellas Pharma US Inc | 6 | $134 |
| Phathom Pharmaceuticals, Inc. | 11 | $129 |
| Kowa Pharmaceuticals America, Inc. | 7 | $123 |
| Dexcom, Inc. | 5 | $114 |
| Alkermes, Inc. | 1 | $110 |
| Pfizer | 5 | $104 |
| Halozyme Inc | 5 | $99 |
| Merck | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Antares Pharma, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Novartis | 2 | $42 |
| Intra-sana Laboratories | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Medicure Pharma Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,467 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $79,163 |
| FarxigaDapagliflozin Propanediol | 52 | $49,752 |
| JardianceEmpagliflozin | 25 | $32,178 |
| JanuviaSitagliptin Phosphate | 27 | $32,001 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $30,231 |
| RybelsusSemaglutide | 18 | $29,620 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $19,546 |
| LinzessLinaclotide | 12 | $19,375 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 17 | $15,037 |
| MounjaroTirzepatide | 13 | $14,122 |
| EliquisApixaban | 11 | $14,117 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $13,843 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $13,203 |
| Clonidine | 26 | $5,878 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $4,225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $2,973 | $108,78273 claims |
| MerckJanuvia, Janumet | $56 | $51,54848 claims |
| AstraZenecaFarxiga | $890 | $49,75252 claims |
| Boehringer IngelheimJardiance | $299 | $32,17825 claims |
| GSKTrelegy Ellipta | $754 | $30,23137 claims |
| AbbVieLinzess, Synthroid | $479 | $20,31824 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $338 | $15,03717 claims |
| Lilly USA, LLCMounjaro | $294 | $14,12213 claims |
| PfizerEliquis | $104 | $14,11711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Huntsville
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Julia BettsHuntsville$27K
- Joann IkardHuntsville$19K
- Hannah GarnettHuntsville$18K
- Alyssa FikesHuntsville$15K
- Justin WilsonCullman$1.1M
- Molly ReevesAuburn$158K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.